Search Results Page

Search Results

1 - 10 of 16 (0.78 seconds)

Novartis Ag & Anr vs Cipla Ltd on 9 January, 2015

treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD). The products emanating from the plaintiffs are internationally known for their superior, high quality ... maintenance therapy to maintain maximal bronchodilation throughout the day in patients with COPD. This would prevent the product needing to be repeatedly dosed. Hence
Delhi High Court Cites 52 - Cited by 5 - M Singh - Full Document

Cipla Limited vs Novartis Ag & Anr on 9 March, 2017

provides symptomatic relief to persons suffering from chronic obstructive pulmonary disease (COPD). 3. The appellant launched its drug ‗UNIBREZ' in October, 2004. However ... small quantities. Thus, the said drug ‗INDACATEROL', which was vital for COPD patients, was not available to large sections of the public in India
Delhi High Court Cites 16 - Cited by 5 - B D Ahmed - Full Document
1   2 Next